Risk, resilience, psychological distress, and anxiety at the beginning of the COVID-19 pandemic in Germany.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 05 2020
revised: 09 06 2020
accepted: 19 06 2020
pubmed: 8 7 2020
medline: 29 12 2020
entrez: 8 7 2020
Statut: ppublish

Résumé

The current COVID-19 pandemic comes with multiple psychological stressors due to health-related, social, economic, and individual consequences and may cause psychological distress. The aim of this study was to screen the population in Germany for negative impact on mental health in the current COVID-19 pandemic and to analyze possible risk and protective factors. A total of 6,509 people took part in an online survey in Germany from 27 March to 6 April. The questionnaire included demographic information and ascertained psychological distress, anxiety and depressive symptoms, and risk and protective factors. In our sample, over 50% expressed suffering from anxiety and psychological distress regarding the COVID-19 pandemic. Participants spent several hours per day thinking about COVID-19 (M = 4.45). Psychological and social determinants showed stronger associations with anxiety regarding COVID-19 than experiences with the disease. The current COVID-19 pandemic does cause psychological distress, anxiety, and depression for large proportions of the general population. Strategies such as maintaining a healthy lifestyle and social contacts, acceptance of anxiety and negative emotions, fostering self-efficacy, and information on where to get medical treatment if needed, seem of help, while substance abuse and suppression of anxiety and negative emotions seem to be associated with more psychological burden.

Sections du résumé

BACKGROUND
The current COVID-19 pandemic comes with multiple psychological stressors due to health-related, social, economic, and individual consequences and may cause psychological distress. The aim of this study was to screen the population in Germany for negative impact on mental health in the current COVID-19 pandemic and to analyze possible risk and protective factors.
METHODS
A total of 6,509 people took part in an online survey in Germany from 27 March to 6 April. The questionnaire included demographic information and ascertained psychological distress, anxiety and depressive symptoms, and risk and protective factors.
RESULTS
In our sample, over 50% expressed suffering from anxiety and psychological distress regarding the COVID-19 pandemic. Participants spent several hours per day thinking about COVID-19 (M = 4.45). Psychological and social determinants showed stronger associations with anxiety regarding COVID-19 than experiences with the disease.
CONCLUSIONS
The current COVID-19 pandemic does cause psychological distress, anxiety, and depression for large proportions of the general population. Strategies such as maintaining a healthy lifestyle and social contacts, acceptance of anxiety and negative emotions, fostering self-efficacy, and information on where to get medical treatment if needed, seem of help, while substance abuse and suppression of anxiety and negative emotions seem to be associated with more psychological burden.

Identifiants

pubmed: 32633464
doi: 10.1002/brb3.1745
pmc: PMC7361063
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e01745

Informations de copyright

© 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

Ann Intern Med. 2020 Aug 18;173(4):317-320
pubmed: 32251513
Brain Behav Immun. 2020 Jul;87:84-92
pubmed: 32335200
Brain Behav. 2020 Sep;10(9):e01745
pubmed: 32633464
BMC Public Health. 2015 Aug 27;15:824
pubmed: 26307047
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Brain Behav Immun. 2020 Aug;88:559-565
pubmed: 32330593
Emerg Infect Dis. 2006 Dec;12(12):1924-32
pubmed: 17326946
Psychol Bull. 2017 Aug;143(8):783-822
pubmed: 28447828
J Ment Health. 2015 Feb;24(1):1-3
pubmed: 25587816
Behav Res Ther. 2020 Apr;127:103573
pubmed: 32087393
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Nervenarzt. 2020 May;91(5):417-421
pubmed: 32221635
PLoS One. 2018 Jul 10;13(7):e0199828
pubmed: 29990349
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
J Affect Disord. 2020 Feb 15;263:621-628
pubmed: 31744741
J Affect Disord. 2020 Jan 1;260:680-686
pubmed: 31550614
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
Depress Anxiety. 2012 Dec;29(12):1014-24
pubmed: 22933460
Behav Res Ther. 2001 Oct;39(10):1249-55
pubmed: 11579992
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518

Auteurs

Moritz Bruno Petzold (MB)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Antonia Bendau (A)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Jens Plag (J)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Lena Pyrkosch (L)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Lea Mascarell Maricic (L)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Felix Betzler (F)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Janina Rogoll (J)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Julia Große (J)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Andreas Ströhle (A)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH